(1) Mosyakin SL and Clemants SE. FURTHER TRANSFERS OF GLANDULAR-PUBESCENT SPECIES FROM CHENOPODIUM SUBG. AMBROSIA TO DYSPHANIA (CHENOPODIACEAE). J Bot Res Inst Tex. (2008) 2: 425-31.
(2) Maksimovic ZA, Dordevic S, and Mraovic M. Antimicrobial activity of Chenopodium botrys essential oil. Fitoterapia. (2005) 76: 112-4.
(3) Bano A, Ahmad M, Hadda TB, Saboor A, Sultana S, Zafar M, Khan MPZ, Arshad M, and Ashraf MA. Quantitative ethnomedicinal study of plants used in the skardu valley at high altitude of Karakoram-Himalayan range, Pakistan. J Ethnobiol Ethnomed. (2014) 10: 43.
(4) Tzakou O, Pizzimenti A, Pizzimenti F, Sdrafkakis V, and Galati E. Composition and antimicrobial activity of Chenopodium botrys L. Essential oil from Greece. J ESSENT OIL RES. (2007) 19: 292-4.
(5) Morteza-Semnani K. A Review on Chenopodium botrys L.: traditional uses, chemical composition and biological activities. mazums-pbr. 2015; 1 (2) :1-9
(6) Buchbauer G, Jirovetz L, Wasicky M, Walter J, and Nikiforov A. Headspace Volatiles of Chenopodiumbotrys (Chenopodiaceae). J ESSENT OIL RES. (1995) 7: 305-8.
(7) Li Y, Li T, Miao C, Li J, Xiao W, and Ma E. β‐Eudesmol induces JNK‐dependent apoptosis through the mitochondrial pathway in HL60 cells. Phytother Res. (2013) 27: 338-43.
(8) Bold RJ, Termuhlen PM, and McConkey DJ. Apoptosis, cancer and cancer therapy.Surg Oncol. (1997) 6: 133-42.
(9) Riedl SJ and Salvesen GS. The apoptosome: signalling platform of cell death. Nat Rev Mol Cell Biol. (2007) 8: 405.
(10) Gillings AS, Balmanno K, Wiggins CM, Johnson M, and Cook SJ. Apoptosis and autophagy: BIM as a mediator of tumour cell death in response to oncogene‐targeted therapeutics. FEBS J. (2009) 276: 6050-62.
(11) Tait SW and Green DR. Mitochondria and cell death: outer membrane permeabilization and beyond. Nat Rev Mol Cell Biol. (2010) 11: 621.
(12) Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, and Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. (2015) 136: E359-E86.
(13) Xue Y, Toh SY, He P, Lim T, Lim D, Pang CL, Abastado J-P, and Thierry F. HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma. Oncotarget. (2015) 6: 34979.
(14) Clarke MF and Fuller M. Stem cells and cancer: two faces of eve. Cell. (2006) 124: 1111-5.
(15) Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, and Beach D. p21 is a universal inhibitor of cyclin kinases. nature. (1993) 366: 701.
(16) Harper JW, Adami GR, Wei N, Keyomarsi K, and Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. cell. (1993) 75: 805-16.
(17) El-Deiry W, p21/p53, cellular growth control and genomic integrity, in Cyclin dependent kinase (CDK) inhibitors. 1998, Springer. p. 121-37.
(18) Jiang H, Lin J, Su Z, Herlyn M, Kerbel RS, Weissman BE, Welch DR, and Fisher PB. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene. (1995) 10: 1855-64.
(19) Vidal M, Loganzo JF, Hayward N, and Albino A. Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res. (1995) 5: 243-50.
(20) Srivastava S, Somasagara RR, Hegde M, Nishana M, Tadi SK, Srivastava M, Choudhary B, and Raghavan SC. Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep. (2016) 6: 24049.
(21) Ghobrial IM, Witzig TE, and Adjei AA. Targeting apoptosis pathways in cancer therapy. CA Cancer J Clin. (2005) 55: 178-94.
(22) Debatin K-M. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. (2004) 53: 153-9.
(23) Kletter C and Kriechbaum M, Tibetan medicinal plants. 2001: CRC Press.
(24) El-Sayed AM, Al-Yahya M, and Hassan MM. Chemical composition and antimicrobial activity of the essential oil of Chenopodium botrys growing in Saudi Arabia. Int J Crude Drug Res (1989) 27: 185-8.
(25) Bedrossian AG, Beauchamp PS, Bernichi B, Dev V, Kitaw KZ, Rechtshaffen H, Bottini AT, and Hope H. Analysis of North American Chenopodium botrys essential oil isolation and structure of two new sesquiterpene alcohols. J ESSENT OIL RES. (2001) 13: 393-400.
(26) Feizbakhsh A, Sedaghat S, Tehrani MS, Rustaiyan A, and Masoudi S. Chemical composition of the essential oils of Chenopodium botrys L. from two different locations in Iran. J ESSENT OIL RES. (2003) 15: 193-4.
(27) Pachon G, Rasoanaivo H, Azqueta A, Rakotozafy J, Raharisololalao A, DE CERAIN AL, De Lapuente J, Borras M, Moukha S, and Centelles J. Anticancer effect of a new benzophenanthridine isolated from Zanthoxylum madagascariense (Rutaceline). In vivo. (2007) 21: 417-22.
(28) Abbas T and Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer. (2009) 9: 400.
(29) Xia M, Knezevic D, and Vassilev L. p21 does not protect cancer cells from apoptosis induced by nongenotoxic p53 activation. Oncogene. (2011) 30: 346.
(30) Taylor WR and Grabovich A, Targeting the cell cycle to kill cancer cells, in Pharmacology. 2009, Elsevier. p. 429-53.
(31) Alkhalaf M and El-Mowafy A. Overexpression of wild-type p53 gene renders MCF-7 breast cancer cells more sensitive to the antiproliferative effect of progesterone. J Endocrinol. (2003) 179: 55-62.
(32) Antony ML, Kim S-H, and Singh SV. Critical role of p53 upregulated modulator of apoptosis in benzyl isothiocyanate-induced apoptotic cell death. PLoS One. (2012) 7: e32267.
(33) Follis AV, Llambi F, Merritt P, Chipuk JE, Green DR, and Kriwacki RW. Pin1-induced proline isomerization in cytosolic p53 mediates BAX activation and apoptosis. Mol cell. (2015) 59: 677-84.
(34) Kanthan R, Senger J-LB, and Diudea D. Malignant mixed Mullerian tumors of the uterus: histopathological evaluation of cell cycle and apoptotic regulatory proteins. World J Surg Oncol. (2010) 8: 60.
(35) Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang HG, and Reed JC. Immunohistochemical determination of in vivo distribution of Bax, a dominant inhibitor of Bcl-2. Am J Pathol. (1994) 145: 1323.
(36) Bojilov D, Dagnon S, and Ivanov I. Constituent composition of Chenopodium botrys essential oil. Bulg. Chem. Commun. (2017) 49: 124-9.
(37) Chalabian, F., Monfared, A., Larijani, K., Saldoosi, S. Comparison of the Essential Oils of Chenopodium botrys L., Ferulago subvelutina Rech.F, Rosa gallica L. and Antimicrobial Activity of the Oils against some Microbes. , 2006; 22(2): 146-154. doi: 10.22092/ijmapr.2006.114989